Lifecore Biomedical Reports Board and Officer Changes
Ticker: LFCR · Form: 8-K · Filed: Apr 16, 2025 · CIK: 1005286
| Field | Detail |
|---|---|
| Company | Lifecore Biomedical, Inc. \De\ (LFCR) |
| Form Type | 8-K |
| Filed Date | Apr 16, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, executive-appointments
TL;DR
Lifecore Biomedical just swapped out some execs and board members, filing shows.
AI Summary
On April 11, 2025, Lifecore Biomedical, Inc. reported a change in its board of directors and executive officers. The filing indicates the departure of certain officers and directors, along with the election of new directors and the appointment of new officers. Specific details regarding the individuals involved and the exact nature of the compensatory arrangements for the new officers were not fully disclosed in this initial filing.
Why It Matters
Changes in a company's leadership and board can signal shifts in strategy, operational focus, or governance, potentially impacting future performance and investor confidence.
Risk Assessment
Risk Level: medium — Changes in key leadership and board composition can introduce uncertainty regarding future strategy and operational stability.
Key Numbers
- 000-27446 — SEC File Number (Identifies the company's filing history with the SEC.)
- 94-3025618 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Lifecore Biomedical, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- April 11, 2025 (date) — Date of earliest event reported
- 3515 Lyman Boulevard, Chaska, Minnesota 55318 (address) — Principal executive offices
FAQ
What specific roles have been affected by the departures and appointments at Lifecore Biomedical?
The filing indicates changes in 'Directors or Certain Officers' and 'Appointment of Certain Officers' but does not specify the exact roles or names of the departing or newly appointed individuals in this section.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this filing occurred on April 11, 2025.
What is Lifecore Biomedical's principal executive office address?
The principal executive offices are located at 3515 Lyman Boulevard, Chaska, Minnesota 55318.
What is the company's state of incorporation?
Lifecore Biomedical, Inc. is incorporated in Delaware.
Does the filing detail the compensatory arrangements for the newly appointed officers?
The filing lists 'Compensatory Arrangements of Certain Officers' as an item, but the specific details of these arrangements are not provided within the provided text.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 16, 2025 regarding LIFECORE BIOMEDICAL, INC. \DE\ (LFCR).